RBC Capital Maintains Outperform on Stryker, Lowers Price Target to $420

Benzinga Newsdesk www.benzinga.com Negative 94.3%

Neg 94.3% Neu 0% Pos 0%

RBC Capital analyst Kendall Au maintains Stryker (NYSE:SYK) with a Outperform and lowers the price target from $435 to $420.